PEOPLE: Silicon Genetics Hires New Marketing VP; GCI s Dougherty Leaves for Drug Developer

This update serves to clarify a misstatement of fact. Michael Pellini, CEO of Genomics Collaborative, will not become COO of the company following Michael Dougherty's departure. Instead, he will assume the title of president and CEO. GenomeWeb regrets the error.

NEW YORK, Nov. 13-Silicon Genetics appointed Kevin Wandryk as vice president of marketing and business development, the company said today.

He was previously in marketing at the internet B-to-B software companies Quova and AdKnowledge, and had spent 10 years at Adobe Systems.

Silicon Genetics, based in Redwood City, Calif., is  a bioinformatics company that builds gene expression anlysis software.

Genomics Collaborative president and chief operating officer Michael Dougherty has joined Adolor as senior vice president of commercial operations, the company said on Nov. 7.

Dougherty joined GCI in January 2001. Prior to that, he spent seven years at Magainin Pharmaceuticals, now called Genaera Corporation, where he was eventually promoted to CEO.

GCI chief executive officer Michael Pellini, who originally joined the company in July 1999, will now also take on the role of president.

Adolor is a drug-development company focusing on treatments for pain.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.